42: the answer to everything? We are so excited to share our study led by the fantastic
@leiendeckerlu
&
@fh_fingolfin
, which identified HPV42 as an oncogenic
#virus
that causes skin
#cancer
& a germ cell-like program conserved in all HPV+ cancers. 🧵👇/1
"This is why non-immunologists hate immunologists..." The fantastic
@EJohnWherry
explains the basics of cancer immunology with a focus on T cells in his beautiful and extremely clear lecture
@AACR
#AACR22
. I really recommend watching it, it's a gem - both in content and delivery.
We are so excited to finally share our new study reporting the evolution of cross-resistance between targeted therapy and immunotherapy, published today
@NatureCancer
. Highlights in the 🧵👇 Free access here 1/25
We are so excited to present our functional
#lineagetracing
tool, CaTCH, developed in the
@obenaufa
lab
@IMPvienna
published
@naturebiotech
. Have you ever wondered if a phenotype is pre-existing in a cell or whether it is acquired during selection? Then👇might be your tool!1/14
I am delighted to announce that I have been promoted to a Senior Group Leader w tenure
@IMPvienna
🥳.
Importantly, this recognizes the work of every single lab member past & present ❤️! So grateful also to mentors & colleagues all over 🌍 f their continuous support & inspiration.
We are happy to share that Andrea Pauli (
@PauliGroup
) Anna Obenauf (
@obenaufa
) are promoted to senior scientists and will continue to help shape the IMP as a top-place for science & a great institution to be at for years to come! 🎉
#WomenInSTEM
Feeling incredibly blessed to be elected as a full
@EMBO
member. A huge thanks to my team (past & present) for turning curiosity into discovery! Also, deep gratitude to my mentors guiding my journey, a special shout-out to
@Johanna_A_Joyce
and my brilliant colleagues
@IMPvienna
!
Thrilled to announce that our
#UnlockIT
project received
#ERCCog
funding! 🎉 We aim to unlock immune responses by exploring tumor evolution during targeted therapy. Huge thanks to my team , colleagues, my partner, family, reviewers, and the panel. 🙌
📢 Results of the 2023 ERC Consolidator Grant competition are out.
€627 million for 308 researchers.
Who has been offered funding?
What topics and questions will they investigate?
Where will they conduct their research?
🇪🇺
@HorizonEU
#ERCCoG
news 👉
Wondering which CRISPR screening platform with single cell readout is the right one for you? This is a nice and up to date overview of what is out there.
@AdvSciNews
Well done!
Our first cover🥳! I can't tell you how happy it makes me to see our work featured
@NatureCancer
. Cover art by my brilliant sis
#LisaObenauf
incidentally merging the names of first and last author😉 Pls👀paper or see Tweetorial 👉
Really happy to become a member of the
@EMBO_YIP
community. A big thank you to my entire team and collaborators for making this possible! 🙏 to my mentors & colleagues &
@IMPvienna
@viennabiocenter
for providing a fantastic environment to start a lab 🙏also to the reviewers 😊🥳
Two out of 26 newly lected EMBO Young Investigators are IMP faculty members! Congratulations, Anna Obenauf & Clemens Plaschka (
@obenaufa
&
@plaschka_lab
)!
👉
I am honored and excited to receive the 2022 AAAS Martin and Rose Wachtel Cancer Research Award and look forward to my virtual lecture
#register
➡️ everyone is welcome!
Thank you
@aaas
@ScienceTM
f selecting me &
@Brit_in_Vienna
& JMP
@IMPvienna
f support!
This is where it all started
in the summer of 2010 🐣 and I'm so excited to be back at
@MSKCancerCenter
for a CBG seminar on Monday hosted by
@TuomasTammela
to present some of our newest findings. Looking forward to seeing old friends, making new connections and enjoying NYC!
Please see the Angelika Amon Young Scientist
#Award
for excellent
#PhD
students outside the US (deadline 30.5.) to honour Angelika as a scientist, mentor, and role model
@kochinstitute
@IMPvienna
I'm thrilled to see
@Johanna_A_Joyce
receive the EACR Award for Women in Cancer Research, recognizing her outstanding scientific achievements and mentorship, which I experienced firsthand even though I wasn't in her lab.
I am so grateful to have an ally like you, Johanna. 🙏
For anyone who needs faith that high quality preclinical science is clinically relevant -- look at this beautiful study by
@obenaufa
in
@NatureCancer
that is now confirmed in a phase 3 clinical trial (see below) Keep up the great work!
Attending the
#HallmarkOfCancer
conference here in Lausanne was amazing! The best part? The people! ❤️ Catching up with old
#friends
, making new ones, starting new
#collaborations
, discussing about new data just because… I missed this so much! Thank you all!! And now 😷🛫🎡👧🏼 🔬
🌟We are delighted to invite you to our EMBO Workshop on "The many faces of cancer evolution" in a breathtaking location! Enjoy interdisciplinary discussions, get new perspectives, and make new friends over an aperitivo!
#EMBOcancerEvo
📅 Don't miss out:
I love this quote that appeared in my inbox from
@EACRnews
today:
"The best way to have a good idea is to have a lot of ideas." Linus Pauling (1901-1994)
Very proud that our first PhD student graduated - Congrats Dr.
@LisaHaas0107
for a super successful time in the lab. Watch out for her main PhD work coming out soon!
#vbcphdstudentsrock
thank you to the 3 amazing women GL examining her
@msmelanoma
Veronika Sexl and Maria Sibilia.
When you are nervous in the morning because you host the most important scientific event of the year at your institute and your toddler is in the bathroom and really calm for a few minutes… 👇 ✂️👧🏼 🙈
@Momademia
#worklifeintegration
I am so excited to have our work featured in
@ScienceTM
in honour of the
@aaas
2022 Wachtel Cancer Research Award! Thx to everyone who made this possible, first & foremost: my awesome lab!
Thx to
@JWilmott38
for providing the pretty cover image!
I am honored and excited to receive the 2022 AAAS Martin and Rose Wachtel Cancer Research Award and look forward to my virtual lecture
#register
➡️ everyone is welcome!
Thank you
@aaas
@ScienceTM
f selecting me &
@Brit_in_Vienna
& JMP
@IMPvienna
f support!
How are tumors escaping control by the immune system? We, located at the
@viennabiocenter
are hiring a motivated master student to help us solve this problem. Start asap, 9-12 months minimum, the student will receive a stipend. Please check out and pls RT.
So happy to share that the
@FWF_at
will support our project, which we hope will help pave the way for immunotherapies in children with bone cancer. I am really excited to work with the Dart2OS team to make a difference for these children and their families!
I am delighted to welcome my former mentor Joan Massague
@LabMassague
@MSKCancerCenter
to
@IMPvienna
in Vienna as part of our high-profile lecture series honoring Max Birnstiel. Can't wait to catch up!
#Cancer
biologist Joan Massagué (
@LabMassague
,
@MSKCancerCenter
), will give the Birnstiel Lecture "Metastatic Cells and Ecosystems" at the IMP lecture hall on 28 April 2022. 👉
Excited to share our latest review: Allies or Enemies—The Multifaceted Role of Myeloid Cells in the Tumor Microenvironment spearheaded by my talented student Lisa Haas
I didn’t understand a word of
#spanish
But I could sense that this was a very special moment
@J_RodriguezVita
. Very happy that you received this important recognition. ☺️
Fantastic to kick off the
#EESMetastasis
meeting with
@Johanna_A_Joyce
highlighting the importance of the
#TME
on metastatic spread, outgrowth and therapy response
The EACR's latest Top 10 Cancer Research Publications is available now. Curated by the EACR Board, it's a summary of the most interesting and impactful recent papers in
#cancerresearch
.
Read it in
#TheCancerResearcher
:
First time I heard
@DirenaAC
former
@LoweLabMSKCC
speak about her work. Fantastic work and exciting vision
@IRBBarcelona
is lucky to have recruited her and I am so excited to have her here in Europe
#WomenInSTEM
. She is recruiting!
I had a wonderful time during my visit at
@nyuniversity
. Thanks to
@iannisaifantis1
for hosting me and everyone who joined the seminar and for the lively discussion! It made my day! Plus amazing dinner at LaMercerie.
So proud of my student
@AnaisElewaut
for stepping up and presenting our work at
#EACR24
while I have to deal with a family emergency. Grateful to the organizers of
@EACRnews
for making this possible and to my amazing lab and supportive colleagues.❤️
#cancerresearch
@TrainingVbc
Are you organising a scientific
#conference
and want to invite young speakers with an excellent track record? Please look into the EMBO YIP
#YoungInvestigatorLectures
that support the invitation of
@EMBO_YIP
members. Win-win!
Very grateful to
@AlexsLemonade
for supporting our research on osteosarcoma metastasis & treatment resistance to get one step closer to a cure. It is so humbling to talk to parents who have lost their child to this cancer & we'll do our best to make a difference.🙏
@ASweetcordero
Congrats to
@obenaufa
, who will be part of an international research efforts to study metastatic spread of osteosarcoma, a bone cancer that mostly affects children and young adults. Part of
@AlexsLemonade
's "Crazy-8 initiative", led by
@ASweetcordero
.
👉
📣Calling all
#CancerBiology
enthusiasts! We're curating topics for the 2024 edition of
@AnnualReviews
. What burning issues or breakthroughs would you like us to cover? Your ideas could shape our content! Please comment below or DM your suggestions.
#AcademicChatter
📚🔬
I wish I could always be as effective and productive as I am on the day before I submit a research grant proposal. I assume/hope I'm not alone in that? 😅
Super excited to connect with the Australian cancer community at
@LorneCancer
conference over the next past days & will also be heading to
#Sydney
next week - say Hi & DM me if you'd like to connect & chat about science!
#cancer
#immunology
also we are👀postdocs/bioinformaticians
#jobalert
Would YOU like to join my team
@IMPvienna
?
For our collaboration projects with
@Boehringer
we are looking for a research assistant with passion for cancer biology and experience with in vivo cancer models.
We would ❤️ to meet you. See 👇
🌟 Job Alert - Pls RT: We're expanding our research team
@IMPvienna
and seeking a passionate Research Assistant/Technician for an exciting collaboration with
@Boehringer
👩🔬 Bring your skills, enthusiasm, and join a world-class research environment.
👉
Combinatorial Studies to Overcome Resistance to Immunotherapy:
@obenaufa
,
@JenWargoMD
, and Jedd Wolchok
@sloan_kettering
will address this topic in a plenary session at the AACR Virtual Meeting on Tumor Immunology and Immunotherapy, Oct 5-6:
#AACRtii21
Why are certain mutations so prevalent in some but not other cancers? A clue: They need to cooperate with lineage-specific transcription factors to activate an oncogenic programme. Really beautiful paper out in
@Nature
by
@SVanharanta
and his team. Btw, he's hiring
@helsinkiuni
!
We are very excited to share our new paper out today
@Nature
, in which we demonstrate that common kidney
#cancer
causing genetic alterations need transcriptional lineage factors for oncogene activation. Details in the thread👇
@AlejoFraticelli
Just stumbled upon this interview of
@LukeGilbertSF
@arcinstitute
and really appreciate
@AngelikaAmon
as a scientist and mentor. This may just be the answer you are looking for. As for practicalities: core funding, collaborations, side project of your current team members…
To develop a Rosetta stone of immune populations in health and disease - a goal of
@IdoAmitLab
that he works towards by developing and using very innovative and powerful single cell technologies. Thanks for joining us today
@AACR
#AACR22
and for the interesting discussion.
🌟 As an Associate Editor at
@jitcancer
, I'm always grateful when reviewers who can't commit recommend alternative experts! It's an excellent opportunity to involve younger scientists & recognize their contributions. Thank you for fostering a supportive scientific community! 🙌
🥳🤩Wow! So excited about the two amazing speakers that will join me for the session “
#Technologies
to Understand Malignant Clonal Behavior at
#SingleCell
Resolution” I am chairing at
#AACR22
@AACR
. Prepare for some 🎆 it is going to be super cool!
We are hiring!! The
@IMPvienna
is looking for a new junior group leader with a curiosity-driven, innovative research program in fundamental and biomedical science. It's an amazing place with lots of freedom to do the science you dream of - please spread the word!
So proud of my PhD student Lukas Leiendecker for receiving an
@oegdv
#award
for our discovery of a novel oncogenic virus as the driver of a skin cancer out
@CD_AACR
👇
Congrats to PhD student Lukas Leiendecker from the lab of Anna Obenauf (
@obenaufa
) for winning the Science Award of the Austrian Society of Dermatology & Venereology (
@oegdv
)! 🥳 1/2
Absolutely essential reading! Warmest congratulations to
@johanna_a_joyce
and the entire team of authors for their pivotal work on spelling out a comprehensive framework for understanding and treating cancer.
"Embracing
#cancer
complexity: Hallmarks of systemic disease"
It was a privilege to contribute to this
#Cell
review, with an incredible group of scientists!
Our forward-looking perspective ⬇️ - incl. the
#tumor
#microenvironment
as a critical target 🎯
It was my pleasure to host this years symposium for the Beug Metastasis Prize given to
@FendtLab
@alpcorreia
@alteam_patricia
@IMPvienna
. Congrats to all the awardees - fantastic to have them here and share their exciting research with us.
Thank you so much for having me! I had a wonderful time and was yet again incredibly impressed by the impactful science happening in the Lausanne area and the excellent presentations by students and postdocs. Now looking forward to dinner w
@MikaelPittet
Olivier Michielin et al.
Thanks to all at the Swiss Cancer Center Leman for an incredible and inspiring annual retreat!
Two wonderful days of science, rich discussions, and brilliant presentations including from our outstanding keynote speaker Anna Obenauf 🤩
@obenaufa
@IMPvienna
There were several exciting developments in the field of lineage tracing and barcoding technologies in the past 2 years, but this remains a nice overview and fantastic read - not just for those interested in
#development
! 👏
@james_gagnon
@aaron_mckenna
"🎉Celebrating the exceptional
#MeinradBusslinger
&
#JanMichaelPeters
@IMPvienna
.
Their lasting impact on science is not only reflected in their own groundbreaking work, but also in the captivating presentations by former trainees & close friends at the anniversary symposium.😍
To quote my student
@leiendeckerlu
here: "Spectacular results" and I couldn't agree more "The HPV immunisation programme has successfully almost eliminated cervical cancer in women born since Sept 1, 1995" 🥳
#vaccineswork
#immunityrocks
The early career fellowships of Human Technopole offers 1 million EUR for five years to bring excellent young scientists to Italy
If you:
<8 years from your PhD
have an innovative idea
are ready to start your lab in 2021
Deadline: January 31, 2021
We are so excited to finally share our new study reporting the evolution of cross-resistance between targeted therapy and immunotherapy, published today
@NatureCancer
. Highlights in the 🧵👇 Free access here 1/25
I am really enjoying the
#ifit2023
conference - fantastic science and great to meet old friends and make new ones! Big plus:
#childcare
available for free in the family hotel and kid loves it! ❤️
I really enjoyed my time in Tuebingen and the fantastic discussions with group leaders, postdocs and students! Thank you
@CoE_iFIT
and Lars Zender for hosting me.
Hi
@Quartzy
- is it true that from July onwards you will be charging also academic labs for using your basic order tracking system ($79/5 users)? Do I remember your
#freeforever
pledge correctly? Thanks for clarifying.
#AcademicChatter